We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
Oral Health and Preventive Dentistry
Login:
username:

password:

Plattform:

Forgotten password?

Registration

Oral Health Prev Dent 17 (2019), No. 6     20. Dec. 2019
Oral Health Prev Dent 17 (2019), No. 6  (20.12.2019)

Page 585-589, doi:10.3290/j.ohpd.a43165, PubMed:31508602


An Analysis of Resistance Patterns of Oral Streptococci Obtained from Orofacial Infections Against Beta-lactams, Clindamycin and Vancomycin over 2014-2018
Leszczynski, Piotr / Sokol-Leszczynska, Beata / Mlynarczyk, Andrzej / Sawicka-Grzelak, Anna / Mlynarczyk, Grazyna
Purpose: Comparison of viridans group Streptococcus (VGS) susceptibility to benzylpenicillin, ampicillin, clindamycin and vancomycin in order to determine resistance rates to assess whether guidelines for prophylactic or therapeutic antibiotic treatment include the present resistance patterns.
Materials and Methods: A retrospective analysis of antimicrobial susceptibility testing (AST) over 4 consecutive years (2014-2017) and 4 months in 2018 for 779 VGS isolates (cumulative data). Isolates originated from pus from orofacial infections cases and tissue fragments from patients undergoing maxillofacial surgeries
Results: The highest resistance rate was observed to clindamycin. The highest overall resistance rate was for Streptococcus parasanguinis 43% and S. constellatus 49%; the lowest was for S. anginosus 12%. All S. anginosus isolates were susceptible to ampicillin during tested period. All isolates of analysed species were susceptible to vancomycin through studied period.
Conclusion: Due to high resistance levels, individual antibiotic susceptibility testing for strains should become mandatory.

Keywords: Streptococcus viridians (VGS), susceptibility, clindamycin, resistance rate